Teva Pharmaceuticals USA

TEVA Pharmaceuticals USA is one of the nation' s leading generic pharmaceutical manufacturers. Formed in 1996 from the merger of Lemmon Company and Biocraft Laboratories. At TEVA Pharmaceuticals USA, business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. Markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories. After acquisitions of Novopharm Ltd. and Copley Pharmaceutical, Inc., Teva USA is an important pharmaceutical manufacturer based on new retail prescription volume in the U.S. Has one of the broadest product lines in the generic industry, with nearly 150 products and well over 400 SKU's.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Generics
- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: